Jordan Johnson/LinkedIn
Nov 4, 2024, 10:43
Jordan Johnson: Keeping the medical decision discretion in the hands of the Radiation Oncologists
Jordan Johnson, Founder and Principal at Bridge Oncology, shared a post on LinkedIn:
“The Final Rule is out:
MPFS 1807-F.
The work by Bridge Oncology, Sean McBride and many others to keep the medical decision discretion in the hands of the Radiation Oncologists.
Strong work!
To see our letter see the link.”
More posts featuring Jordan Johnson.
Jordan Johnson is the Founding Partner of Bridge Oncology and serves on the Board of Directors for the National Association of Medication Access and Patient Advocacy. He is also the Founder of The Healthcare Hub and LegacybyImpact.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 10, 2025, 15:01
May 10, 2025, 15:01
May 10, 2025, 14:14
May 10, 2025, 14:11
May 10, 2025, 13:57